Department of Radiology, University Medical Center Utrecht, the Netherlands.
AJNR Am J Neuroradiol. 2011 Jun-Jul;32(6):1030-3. doi: 10.3174/ajnr.A2438. Epub 2011 Mar 10.
Impairment of the cerebral autoregulation is an important predictor of TIA and stroke in patients with an ICA stenosis. The autoregulative status can be assessed directly by measuring the vasodilatory capacity of the cerebral arteries. The aim of our study was to investigate the vasodilatory capacity of the proximal and distal cerebral vasculature in patients with an ICA stenosis and healthy control subjects by combining MRA with an acetazolamide provocation challenge.
Fourteen functionally independent patients (mean age, 67.2 ± 8.7 years) with a symptomatic ICA stenosis and 19 healthy controls (mean age, 63.1 ± 7.2 years) were included. MRA was performed before and 20 minutes after intravenous administration of acetazolamide. The vasodilatory capacity of 11 proximal and distal cerebral vessels was assessed by measuring the increase in vessel diameter after acetazolamide.
In the hemisphere ipsilateral to the ICA stenosis, there was no increase in diameter after acetazolamide, whereas a significant increase was measured in the contralateral hemisphere for the A1 and A2 segments of the ACA, the pericallosal artery, and the BA. A significant diameter increase was measured in all except 1 vessel of the controls. The vasodilatory capacity was significantly lower ipsilateral to the ICA stenosis compared with the A1 segment of the ACA and the P2 segment of the PCA in the controls.
MRA combined with an acetazolamide provocation challenge can measure normal and impaired vasodilatory capacity of the cerebral vasculature.
大脑自动调节功能障碍是颈内动脉狭窄患者短暂性脑缺血发作和中风的重要预测因素。自动调节状态可以通过测量脑动脉的血管舒张能力来直接评估。我们的研究目的是通过将磁共振血管造影(MRA)与乙酰唑胺激发挑战相结合,来研究颈内动脉狭窄患者和健康对照组近端和远端脑血管的血管舒张能力。
纳入了 14 名有症状性颈内动脉狭窄且功能独立的患者(平均年龄 67.2±8.7 岁)和 19 名健康对照者(平均年龄 63.1±7.2 岁)。在静脉注射乙酰唑胺前和 20 分钟后进行 MRA。通过测量乙酰唑胺后血管直径的增加来评估 11 个近端和远端脑血管的血管舒张能力。
在颈内动脉狭窄同侧的半球中,乙酰唑胺后没有直径增加,而在对侧半球的 ACA 的 A1 和 A2 段、胼胝体动脉和基底动脉则有显著的直径增加。除了 1 名对照组患者外,其他所有人的血管都有显著的直径增加。与对照组的 ACA 的 A1 段和 PCA 的 P2 段相比,颈内动脉狭窄同侧的血管舒张能力显著降低。
MRA 结合乙酰唑胺激发挑战可以测量脑血管的正常和受损的血管舒张能力。